Trial intelligence / Profile preview

AZD8529 for Smoking Cessation in Female Smokers

NCT02401022Phase 2Completed

Sponsor
National Institute on Drug Abuse
Start
Jul 2015
Primary completion
Nov 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of AZD8529 in Tobacco Use Disorder (TUD), sponsored by National Institute on Drug Abuse. Started Jul 2015; status: completed.

02

Drugs

AZD8529
03

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT02401022.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02401022.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call